Cayston 75 mg (Aztreonam POWDER FOR SOLUTION) 75 MG

CAYSTON 75 MG is an inhalation solution containing aztreonam, used to manage chronic pulmonary infections in cystic fibrosis patients. This powder for solution is designed for easy administration via nebulizer.

Strength

75 MG

Pack Size

2ML

Manufacturer / TM Owner

GILEAD SCIENCES CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CAYSTON 75 MG is primarily used for the management of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis. This medication is specifically formulated for inhalation, targeting the lungs directly. It is often prescribed as part of a comprehensive treatment plan to improve respiratory function and reduce infection-related symptoms.

Side Effects

Common effects of CAYSTON 75 MG may include cough, wheezing, and throat irritation. Some users might experience changes in taste or mild respiratory discomfort. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

CAYSTON 75 MG should be handled with care, ensuring proper storage and preparation of the solution. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with known allergies to aztreonam or similar antibiotics should consult their healthcare provider before use.

Avoid Interactions

CAYSTON 75 MG may interact with other medications, particularly those that affect kidney function. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.

Frequently Asked Questions

CAYSTON 75 MG is used to manage chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

CAYSTON 75 MG is administered via inhalation using a nebulizer. The powder should be prepared as a solution according to the provided instructions.

Common side effects may include cough, wheezing, throat irritation, and changes in taste. These effects are usually temporary.

It is important to consult a healthcare provider before using CAYSTON 75 MG with other medications, as interactions may occur.

Patients with known allergies to aztreonam or similar antibiotics should avoid using CAYSTON 75 MG unless advised otherwise by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.